Fosun Internationalは2025年TVBEG賞で最優秀賞を受賞し、世界的持続可能性と医療革新を受賞した。 Fosun International won top honors at the 2025 TVB ESG Awards for its global sustainability and innovation in healthcare.

Fosun Internationalは2025年TVBEG賞の最優秀受賞者と名づけられ,"ESGの練習のベスト"や"ESGのBest in ESGレポート"などを受賞した. Fosun International was named the top winner at the TVB ESG Awards 2025, receiving the "Outstanding ESG Award" along with honors for "Best in ESG Practices" and "Best in ESG Report." 2025年12月19日に香港で授与されたこの賞は,健康管理,観光,消費,保険のグローバル事業におけるフォソン社の優れた環境,社会,ガバナンスパフォーマンスを表彰した. The award, presented on December 19, 2025, in Hong Kong, recognized Fosun’s strong environmental, social, and governance performance across its global operations in healthcare, tourism, consumption, and insurance. 同社は,第一項の利用を承認する新型がん治療であるHANSIZHUNGの開発を含め,継続的な努力と革新を称賛した. The company was praised for its sustainability efforts and innovation, including the development of HANSIZHUANG, a new cancer treatment approved for first-line use. Fosunの指導は,R&Dと手頃な医療ソリューションを通じて社会価値を生み出すという任務を強調した. Fosun’s leadership emphasized its mission to create social value through R&D and affordable healthcare solutions.